SAN JOSE, (Reuters) – Costa Rican health authorities yesterday said that after studying the available clinical studies they had decided to reject the delivery of Sinovac Biotech’s COVID-19 vaccine for the time being, saying it was not effective enough.
Earlier this month however, Uruguay released real-world data on the impact of Sinovac’s vaccine among its population that showed it was over 90% effective in preventing intensive care admissions and deaths.
